{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T14:33:52Z","timestamp":1774017232392,"version":"3.50.1"},"reference-count":78,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T00:00:00Z","timestamp":1637798400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003443","name":"Ministry of Education and Science of the Russian Federation","doi-asserted-by":"publisher","award":["RFMEFI60414X0064"],"award-info":[{"award-number":["RFMEFI60414X0064"]}],"id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["09272\/2013"],"award-info":[{"award-number":["09272\/2013"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["15-15-30039"],"award-info":[{"award-number":["15-15-30039"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.vaccine.2021.11.042","type":"journal-article","created":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T16:17:06Z","timestamp":1637770626000},"page":"89-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Immunization with recombinant ORF2 p551 protein protects common marmosets (Callithrix jacchus) against homologous and heterologous hepatitis E virus challenge"],"prefix":"10.1016","volume":"40","author":[{"given":"Ilya","family":"Gordeychuk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Kyuregyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alla","family":"Kondrashova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterina","family":"Bayurova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanislav","family":"Gulyaev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana","family":"Gulyaeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilya","family":"Potemkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia","family":"Karlsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Isaeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alla","family":"Belyakova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Lyashenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexey","family":"Sorokin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexey","family":"Chumakov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Morozov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Isaguliants","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aydar","family":"Ishmukhametov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikhail","family":"Mikhailov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.11.042_b0005","unstructured":"Abbott, D. H., Barnett, D. K., Colman, R. J., Yamamoto, M. E., & Schultz-Darken, N. J. (2003). Aspects of common marmoset basic biology and life history important for biomedical research. In Comparative Medicine (Vol. 53, pp. 339\u2013350). Retrieved from https:\/\/www.ingentaconnect.com\/content\/aalas\/cm\/2003\/00000053\/00000004\/art00002"},{"issue":"20","key":"10.1016\/j.vaccine.2021.11.042_b0010","doi-asserted-by":"crossref","first-page":"11745","DOI":"10.1073\/pnas.95.20.11745","article-title":"The common marmoset: a new world primate species with limited Mhc class II variability","volume":"95","author":"Antunes","year":"1998","journal-title":"PNAS"},{"issue":"7","key":"10.1016\/j.vaccine.2021.11.042_b0015","first-page":"1","article-title":"Utility of Common Marmoset (Callithrix jacchus) Embryonic Stem Cells in Liver Disease Modeling","volume":"11","author":"Aravalli","year":"2020","journal-title":"Tissue Engineering and Drug Metabolism. Genes"},{"issue":"1","key":"10.1016\/j.vaccine.2021.11.042_b0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000149370","article-title":"Evidence for a virus in Non-A, Non-B hepatitis transmitted via the fecal-oral route","volume":"20","author":"Balayart","year":"1983","journal-title":"Intervirology"},{"key":"10.1016\/j.vaccine.2021.11.042_b0025","doi-asserted-by":"crossref","unstructured":"Brok, H. P. M., Hornby, R. J., Griffiths, G. D., Scott, L. A. M., & \u2019T Hart, B. A. (2001). An extensive monoclonal antibody panel for the phenotyping of leukocyte subsets in the common marmoset and the cotton-top tamarin. Cytometry, 45(4), 294\u2013303. 10.1002\/1097-0320(20011201)45:4<294::AID-CYTO10002>3.0.CO;2-C","DOI":"10.1002\/1097-0320(20011201)45:4<294::AID-CYTO10002>3.0.CO;2-C"},{"key":"10.1016\/j.vaccine.2021.11.042_b0030","doi-asserted-by":"crossref","unstructured":"Cao, Y., Bing, Z., Guan, S., Zhang, Z., & Wang, X. (2018, September 2). Development of new hepatitis E vaccines. Human Vaccines and Immunotherapeutics. Hum Vaccin Immunother. 10.1080\/21645515.2018.1469591","DOI":"10.1080\/21645515.2018.1469591"},{"issue":"37","key":"10.1016\/j.vaccine.2021.11.042_b0035","doi-asserted-by":"crossref","first-page":"5073","DOI":"10.1016\/j.vaccine.2017.05.072","article-title":"A phase 1 randomized open-label clinical study to evaluate the safety and tolerability of a novel recombinant hepatitis E vaccine","volume":"35","author":"Cao","year":"2017","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2021.11.042_b0040","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1107\/S0907444906052024","article-title":"His-tag impact on structure","volume":"63","author":"Carson","year":"2007","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"14","key":"10.1016\/j.vaccine.2021.11.042_b0045","doi-asserted-by":"crossref","first-page":"7100","DOI":"10.1128\/JVI.00403-08","article-title":"The Hepatitis E Virus ORF3 Protein Modulates Epidermal Growth Factor Receptor Trafficking, STAT3 Translocation, and the Acute-Phase Response","volume":"82","author":"Chandra","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2021.11.042_b0050","doi-asserted-by":"crossref","unstructured":"Corneillie, L., Banda, D. H., & Meuleman, P. (2019, June 1). Animal models for hepatitis e virus. Viruses. MDPI AG. 10.3390\/v11060564","DOI":"10.3390\/v11060564"},{"issue":"11","key":"10.1016\/j.vaccine.2021.11.042_b0055","doi-asserted-by":"crossref","first-page":"a032144","DOI":"10.1101\/cshperspect.a032144","article-title":"Transmission and Epidemiology of Hepatitis E Virus Genotype 3 and 4 Infections","volume":"8","author":"Dalton","year":"2018","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"key":"10.1016\/j.vaccine.2021.11.042_b0060","unstructured":"Diarrassouba, A., Potemkin, L. A., Lopatukhina, M. A., Isaeva, O. V., Kyuregyan, K. K., & Mikhailov, M. I. (2016). Standardization of diagnostic of hepatitis E. Klinichescheskaya Laboratornaya Diagnostika, 2016-Janua(5), 299\u2013303. 10.18821\/0869-2084-2016-5-299-303"},{"issue":"2","key":"10.1016\/j.vaccine.2021.11.042_b0065","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S1046-5928(02)00614-9","article-title":"One-step purification and refolding of recombinant photoprotein aequorin by immobilized metal-ion affinity chromatography","volume":"27","author":"Glynou","year":"2003","journal-title":"Protein Expr Purif"},{"issue":"4","key":"10.1016\/j.vaccine.2021.11.042_b0070","doi-asserted-by":"crossref","first-page":"63","DOI":"10.32607\/20758251-2018-10-4-63-69","article-title":"Assessment of the Parameters of Adaptive Cell-Mediated Immunity in Na\u00efve Common Marmosets (Callithrix jacchus)","volume":"10","author":"Gordeychuk","year":"2018","journal-title":"Acta Naturae"},{"issue":"3","key":"10.1016\/j.vaccine.2021.11.042_b0075","first-page":"35","article-title":"STUDY OF IMMUNOGENICITY OF A PROTOTYPE VACCINE AGAINST HEPATITIS E. Journal of Microbiology Epidemiology","author":"Gulyaev","year":"2017","journal-title":"Immunobiology"},{"issue":"31","key":"10.1016\/j.vaccine.2021.11.042_b0080","doi-asserted-by":"crossref","first-page":"12992","DOI":"10.1073\/pnas.0904848106","article-title":"Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor binding","volume":"106","author":"Guu","year":"2009","journal-title":"PNAS"},{"issue":"11","key":"10.1016\/j.vaccine.2021.11.042_b0085","doi-asserted-by":"crossref","first-page":"a032573","DOI":"10.1101\/cshperspect.a032573","article-title":"November 1)","volume":"8","author":"Innis","year":"2018","journal-title":"Immunization against Hepatitis E. Cold Spring Harbor Perspectives in Medicine. NLM (Medline)."},{"issue":"1","key":"10.1016\/j.vaccine.2021.11.042_b0090","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0378-1119(90)90336-P","article-title":"High efficiency transformation of Escherichia coli with plasmids","volume":"96","author":"Inoue","year":"1990","journal-title":"Gene"},{"key":"10.1016\/j.vaccine.2021.11.042_b0095","doi-asserted-by":"crossref","unstructured":"Jagessar, S. A., Vierboom, M., Blezer, E. L. A., Bauer, J., \u2019t Hart, B. A., & Kap, Y. S. (2013). An overview of models, methods, and reagents developed for translational autoimmunity research in the common marmoset (Callithrix jacchus). Experimental Animals. Exp Anim. 10.1538\/expanim.62.159","DOI":"10.1538\/expanim.62.159"},{"issue":"1","key":"10.1016\/j.vaccine.2021.11.042_b0100","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1128\/jvi.70.1.207-216.1996","article-title":"Expression in animal cells and characterization of the hepatitis E virus structural proteins","volume":"70","author":"Jameel","year":"1996","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2021.11.042_b0105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jviromet.2005.07.004","article-title":"A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus","volume":"131","author":"Jothikumar","year":"2006","journal-title":"J Virol Methods"},{"issue":"31","key":"10.1016\/j.vaccine.2021.11.042_b0110","doi-asserted-by":"crossref","first-page":"7030","DOI":"10.3748\/wjg.v22.i31.7030","article-title":"August 21). Hepatitis E: Discovery, global impact, control and cure","volume":"22","author":"Khuroo","year":"2016","journal-title":"World J Gastroenterol. Baishideng Publishing Group Co., Limited."},{"key":"10.1016\/j.vaccine.2021.11.042_b0115","doi-asserted-by":"crossref","unstructured":"Kirkwood, C. D., Dobscha, K. R., & Steele, A. D. (2020). Hepatitis E should be a global public health priority: recommendations for improving surveillance and prevention. Expert Review of Vaccines. Taylor and Francis Ltd. 10.1080\/14760584.2020.1874930","DOI":"10.1080\/14760584.2020.1874930"},{"issue":"4","key":"10.1016\/j.vaccine.2021.11.042_b0120","article-title":"Long-term antibody persistence after hepatitis e virus infection and vaccination in Dongtai, China. Open Forum","volume":"6","author":"Kmush","year":"2019","journal-title":"Infectious Diseases"},{"key":"10.1016\/j.vaccine.2021.11.042_b0125","doi-asserted-by":"crossref","unstructured":"Kramer, J. A., Grindley, J., Crowell, A. M., Makaron, L., Kohli, R., Kirby, M., \u2026 Wachtman, L. M. (2014). The Common Marmoset as a Model for the Study of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Http:\/\/Dx.Doi.Org\/10.1177\/0300985814537839, 52(2), 404\u2013413. 10.1177\/0300985814537839","DOI":"10.1177\/0300985814537839"},{"issue":"4","key":"10.1016\/j.vaccine.2021.11.042_b0130","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1600-0684.2012.00550.x","article-title":"Parameters of haematology, clinical chemistry and lipid metabolism in the common marmoset and alterations under stress conditions","volume":"41","author":"Kuehnel","year":"2012","journal-title":"J Med Primatol"},{"issue":"7","key":"10.1016\/j.vaccine.2021.11.042_b0135","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/molbev\/msw054","article-title":"MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets","volume":"33","author":"Kumar","year":"2016","journal-title":"Mol Biol Evol"},{"issue":"3","key":"10.1016\/j.vaccine.2021.11.042_b0140","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s10517-016-3173-0","article-title":"Simulation of Viral Hepatitis E in Marmosets","volume":"160","author":"Kyuregyan","year":"2016","journal-title":"Bull Exp Biol Med"},{"issue":"6","key":"10.1016\/j.vaccine.2021.11.042_b0145","doi-asserted-by":"crossref","first-page":"274","DOI":"10.36233\/0507-4088-2019-64-6-274-280","article-title":"Belgorod region \u2013 the territory endemic for hepatitis E","volume":"64","author":"Kyuregyan","year":"2019","journal-title":"Vopr Virusol"},{"issue":"2","key":"10.1016\/j.vaccine.2021.11.042_b0150","doi-asserted-by":"crossref","first-page":"a031815","DOI":"10.1101\/cshperspect.a031815","article-title":"Nonhuman primate models of hepatitis A virus and hepatitis E virus infections","volume":"9","author":"Lanford","year":"2019","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"issue":"1","key":"10.1016\/j.vaccine.2021.11.042_b0155","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-26975-4","article-title":"HEV ORF3 downregulates TLR7 to inhibit the generation of type I interferon via impairment of multiple signaling pathways","volume":"8","author":"Lei","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2021.11.042_b0165","doi-asserted-by":"crossref","unstructured":"Li, S., Tang, X., Seetharaman, J., Yang, C., Gu, Y., Zhang, J., \u2026 Xia, N. (2009). Dimerization of hepatitis E virus capsid protein E2s domain is essential for virus-host interaction. PLoS Pathogens, 5(8), e1000537. 10.1371\/journal.ppat.1000537","DOI":"10.1371\/journal.ppat.1000537"},{"issue":"22","key":"10.1016\/j.vaccine.2021.11.042_b0170","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1016\/j.vaccine.2004.11.064","article-title":"A bacterially expressed particulate hepatitis E vaccine: Antigenicity, immunogenicity and protectivity on primates","volume":"23","author":"Li","year":"2005","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2021.11.042_b0175","doi-asserted-by":"crossref","first-page":"7207","DOI":"10.1128\/jvi.71.10.7207-7213.1997","article-title":"Expression and self-assembly of empty virus-like particles of hepatitis E virus","volume":"71","author":"Li","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2021.11.042_b0180","doi-asserted-by":"crossref","unstructured":"Li, Y., Huang, X., Zhang, Z., Li, S., Zhang, J., Xia, N., & Zhao, Q. (2020). Prophylactic hepatitis E vaccines: Antigenic analysis and serological evaluation. Viruses. MDPI AG. 10.3390\/v12010109","DOI":"10.3390\/v12010109"},{"issue":"8","key":"10.1016\/j.vaccine.2021.11.042_b0185","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.3390\/ijms11082962","article-title":"A Single Amino Acid Substitution Changes Antigenicity of ORF2-Encoded Proteins of Hepatitis E Virus","volume":"11","author":"Liang","year":"2010","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.vaccine.2021.11.042_b0190","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/hep.28436","article-title":"A nationwide survey of hepatitis E viral infection in French blood donors","volume":"63","author":"Mansuy","year":"2016","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.vaccine.2021.11.042_b0195","doi-asserted-by":"crossref","first-page":"826","DOI":"10.3390\/v12080826","article-title":"August 1). Progress in the production of virus-like particles for vaccination against hepatitis E virus","volume":"12","author":"Mazalovska","year":"2020","journal-title":"Viruses. MDPI AG."},{"issue":"2","key":"10.1016\/j.vaccine.2021.11.042_b0200","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1006\/viro.2001.1093","article-title":"Identification and characterization of the neutralization epitope(s) of the hepatitis E virus","volume":"288","author":"Meng","year":"2001","journal-title":"Virology"},{"issue":"18","key":"10.1016\/j.vaccine.2021.11.042_b0205","doi-asserted-by":"crossref","first-page":"9860","DOI":"10.1073\/pnas.94.18.9860","article-title":"A novel virus in swine is closely related to the human hepatitis E virus","volume":"94","author":"Meng","year":"1997","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2021.11.042_b0210","first-page":"239","article-title":"Gruppovaya zabolevaemost\u2018 gepatitom E v g. Kovrove Vladimirskoy oblasti (Predvaritel\u2018noe soobshchenie) [Group incidence of hepatitis E in Kovrov Vladimir region (preliminary report)]. Meditsinskaya Virusologiya \u2014 Medical","volume":"26","author":"Mikhaylov","year":"2009","journal-title":"Virology"},{"issue":"26","key":"10.1016\/j.vaccine.2021.11.042_b0215","doi-asserted-by":"crossref","first-page":"14648","DOI":"10.1073\/pnas.94.26.14648","article-title":"Role of B cells in antigen presentation of the hepatitis B core","volume":"94","author":"Milich","year":"1997","journal-title":"PNAS"},{"issue":"1","key":"10.1016\/j.vaccine.2021.11.042_b0220","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1053\/j.gastro.2017.09.020","article-title":"Hepatitis E Virus Lifecycle and Identification of 3 Forms of the ORF2 Capsid Protein","volume":"154","author":"Montpellier","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.vaccine.2021.11.042_b0225","doi-asserted-by":"crossref","unstructured":"Nair, V. P., Anang, S., Subramani, C., Madhvi, A., Bakshi, K., Srivastava, A., \u2026 Surjit, M. (2016). Endoplasmic Reticulum Stress Induced Synthesis of a Novel Viral Factor Mediates Efficient Replication of Genotype-1 Hepatitis E Virus. PLoS Pathogens, 12(4), e1005521. 10.1371\/journal.ppat.1005521","DOI":"10.1371\/journal.ppat.1005521"},{"key":"10.1016\/j.vaccine.2021.11.042_b0230","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2016.01419","article-title":"Molecular biology and infection of hepatitis E virus","author":"Nan","year":"2016","journal-title":"Front Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2021.11.042_b0235","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/jmp.12216","article-title":"Comprehensive panel of cross-reacting monoclonal antibodies for analysis of different immune cells and their distribution in the common marmoset (Callithrix jacchus)","volume":"45","author":"Neumann","year":"2016","journal-title":"J Med Primatol"},{"issue":"1","key":"10.1016\/j.vaccine.2021.11.042_b0240","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.yrtph.2010.12.003","article-title":"Overview of the marmoset as a model in nonclinical development of pharmaceutical products","volume":"59","author":"Orsi","year":"2011","journal-title":"Regul Toxicol Pharm"},{"key":"10.1016\/j.vaccine.2021.11.042_b0245","doi-asserted-by":"crossref","unstructured":"Pallerla, S.R., Harms, D., Johne, R., Todt, D., Steinmann, E., Schemmerer, M., \u2026 Velavan, T. P. (2020, October 1). Hepatitis e virus infection: Circulation, molecular epidemiology, and impact on global health. Pathogens. MDPI AG. 10.3390\/pathogens9100856","DOI":"10.3390\/pathogens9100856"},{"key":"10.1016\/j.vaccine.2021.11.042_b0250","doi-asserted-by":"crossref","unstructured":"Primadharsini, P.P., Nagashima, S., & Okamoto, H. (2021). Mechanism of cross-species transmission, adaptive evolution and pathogenesis of hepatitis e virus. Viruses. Viruses. 10.3390\/v13050909","DOI":"10.3390\/v13050909"},{"key":"10.1016\/j.vaccine.2021.11.042_b0255","doi-asserted-by":"crossref","unstructured":"Purdy, M. A., Harrison, T. J., Jameel, S., Meng, X. J., Okamoto, H., Van Der Poel, W. H. M., & Smith, D. B. (2017). ICTV virus taxonomy profile: Hepeviridae. Journal of General Virology, 98(11), 2645\u20132646. 10.1099\/jgv.0.000940","DOI":"10.1099\/jgv.0.000940"},{"issue":"4","key":"10.1016\/j.vaccine.2021.11.042_b0260","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/hep.25505","article-title":"The global burden of hepatitis E virus genotypes 1 and 2 in 2005","volume":"55","author":"Rein","year":"2012","journal-title":"Hepatology"},{"issue":"4948","key":"10.1016\/j.vaccine.2021.11.042_b0265","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1126\/science.2107574","article-title":"Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis","volume":"247","author":"Reyes","year":"1990","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.vaccine.2021.11.042_b0270","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/nar\/15.3.1281","article-title":"The codon adaptation index-a measure of directional synonymous codon usage bias, and its potential applications","volume":"15","author":"Sharp","year":"1987","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"10.1016\/j.vaccine.2021.11.042_b0275","doi-asserted-by":"crossref","first-page":"6031","DOI":"10.1128\/JVI.00444-13","article-title":"The Hepatitis E Virus Capsid C-Terminal Region Is Essential for the Viral Life Cycle: Implication for Viral Genome Encapsidation and Particle Stabilization","volume":"87","author":"Shiota","year":"2013","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2021.11.042_b0280","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJMoa061847","article-title":"Safety and Efficacy of a Recombinant Hepatitis E Vaccine","volume":"356","author":"Shrestha","year":"2007","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.vaccine.2021.11.042_b0285","doi-asserted-by":"crossref","first-page":"5697","DOI":"10.1128\/JVI.00146-12","article-title":"Adaptation of a Genotype 3 Hepatitis E Virus to Efficient Growth in Cell Culture Depends on an Inserted Human Gene Segment Acquired by Recombination","volume":"86","author":"Shukla","year":"2012","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2021.11.042_b0290","doi-asserted-by":"crossref","first-page":"a031880","DOI":"10.1101\/cshperspect.a031880","article-title":"Classification and Genomic Diversity of Enterically Transmitted Hepatitis Viruses","volume":"8","author":"Smith","year":"2018","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"key":"10.1016\/j.vaccine.2021.11.042_b0295","doi-asserted-by":"crossref","unstructured":"Smith, D. B., Simmonds, P., Izopet, J., Oliveira-Filho, E. F., Ulrich, R. G., Johne, R., \u2026 Purdy, M. A. (2016, March 1). Proposed reference sequences for hepatitis E Virus subtypes. Journal of General Virology. Microbiology Society. 10.1099\/jgv.0.000393","DOI":"10.1099\/jgv.0.000393"},{"issue":"4","key":"10.1016\/j.vaccine.2021.11.042_b0300","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1128\/JCM.02002-09","article-title":"Hepatitis e virus (HEV) strains in serum samples can replicate efficiently in cultured cells despite the coexistence of HEV antibodies: Characterization of HEV virions in blood circulation","volume":"48","author":"Takahashi","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2021.11.042_b0305","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1073\/pnas.1912307117","article-title":"Robust hepatitis e virus infection and transcriptional response in human hepatocytes","volume":"117","author":"Todt","year":"2020","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2021.11.042_b0310","doi-asserted-by":"crossref","unstructured":"Wang, B., & Meng, X.J. (2021, January 1). Structural and molecular biology of hepatitis E virus. Computational and Structural Biotechnology Journal. Elsevier B.V. 10.1016\/j.csbj.2021.03.038","DOI":"10.1016\/j.csbj.2021.03.038"},{"key":"10.1016\/j.vaccine.2021.11.042_b0315","first-page":"161","article-title":"Animal models for hepatitis E virus","volume":"Vol. 948","author":"Wang","year":"2016"},{"issue":"1-2","key":"10.1016\/j.vaccine.2021.11.042_b0320","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.virusres.2013.05.013","article-title":"Rabbit and human hepatitis E virus strains belong to a single serotype","volume":"176","author":"Wang","year":"2013","journal-title":"Virus Res"},{"issue":"10","key":"10.1016\/j.vaccine.2021.11.042_b0325","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1128\/JVI.00107-15","article-title":"Characterization of Two Novel Linear B-Cell Epitopes in the Capsid Protein of Avian Hepatitis E Virus (HEV) That Are Common to Avian, Swine, and Human HEVs","volume":"89","author":"Wang","year":"2015","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2021.11.042_b0330","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.cmi.2020.03.039","article-title":"July 1). Hepatitis E: an expanding epidemic with a range of complications","volume":"26","author":"Webb","year":"2020","journal-title":"Clin Microbiol Infect. Elsevier B.V."},{"key":"10.1016\/j.vaccine.2021.11.042_b0335","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.antiviral.2016.02.002","article-title":"Immunogenicity difference between two hepatitis e vaccines derived from genotype 1 and 4","volume":"128","author":"Wen","year":"2016","journal-title":"Antiviral Res"},{"issue":"12","key":"10.1016\/j.vaccine.2021.11.042_b0340","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1016\/j.molimm.2007.01.002","article-title":"Difference of T cell and B cell activation in two homologous proteins with similar antigenicity but great distinct immunogenicity","volume":"44","author":"Wu","year":"2007","journal-title":"Mol Immunol"},{"issue":"31","key":"10.1016\/j.vaccine.2021.11.042_b0350","doi-asserted-by":"crossref","first-page":"12986","DOI":"10.1073\/pnas.0903699106","article-title":"Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structure","volume":"106","author":"Yamashita","year":"2009","journal-title":"PNAS"},{"issue":"20","key":"10.1016\/j.vaccine.2021.11.042_b0355","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.3748\/wjg.v27.i20.2458","article-title":"May 28). Open reading frame 3 protein of hepatitis e virus: Multi-function protein with endless potential","volume":"27","author":"Yang","year":"2021","journal-title":"World J Gastroenterol. Baishideng Publishing Group Co."},{"issue":"18","key":"10.1016\/j.vaccine.2021.11.042_b0360","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1073\/pnas.1721345115","article-title":"Origin, antigenicity, and function of a secreted form of ORF2 in hepatitis E virus infection","volume":"115","author":"Yin","year":"2018","journal-title":"PNAS"},{"issue":"32","key":"10.1016\/j.vaccine.2021.11.042_b0365","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1016\/j.vaccine.2019.04.006","article-title":"Safety and immunogenicity of hepatitis E vaccine in elderly people older than 65 years","volume":"37","author":"Yu","year":"2019","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2021.11.042_b0370","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/jmv.1027","article-title":"Conformational antigenic determinants generated by interactions between a bacterially expressed recombinant peptide of the hepatitis E virus structural protein","volume":"64","author":"Zhang","year":"2001","journal-title":"J Med Virol"},{"issue":"22","key":"10.1016\/j.vaccine.2021.11.042_b0375","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1016\/j.vaccine.2004.11.065","article-title":"Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid protein","volume":"23","author":"Zhang","year":"2005","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2021.11.042_b0380","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.vaccine.2008.12.061","article-title":"Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine","volume":"27","author":"Zhang","year":"2009","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.vaccine.2021.11.042_b0385","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJMx150008","article-title":"Long-term efficacy of a hepatitis E vaccine","volume":"372","author":"Zhang","year":"2015","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.vaccine.2021.11.042_b0390","doi-asserted-by":"crossref","unstructured":"Zhao, Q., Syed, S. F., & Zhou, E. M. (2015, October). Antigenic properties of avian hepatitis E virus capsid protein. Veterinary Microbiology. 10.1016\/j.vetmic.2015.08.016","DOI":"10.1016\/j.vetmic.2015.08.016"},{"issue":"16","key":"10.1016\/j.vaccine.2021.11.042_b0395","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/j.vaccine.2018.03.005","article-title":"Characterization of capsid protein (p495) of hepatitis E virus expressed in Escherichia coli and assembling into particles in vitro","volume":"36","author":"Zheng","year":"2018","journal-title":"Vaccine"},{"issue":"9744","key":"10.1016\/j.vaccine.2021.11.042_b0400","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(10)61030-6","article-title":"Efficacy and safety of a recombinant hepatitis e vaccine in healthy adults: A large-scale, randomised, double-blind placebo-controlled, phase 3 trial","volume":"376","author":"Zhu","year":"2010","journal-title":"The Lancet"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21014870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21014870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:08:18Z","timestamp":1759403298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21014870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0264410X21014870"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.11.042","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunization with recombinant ORF2 p551 protein protects common marmosets (Callithrix jacchus) against homologous and heterologous hepatitis E virus challenge","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.11.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}